To treat or not to treat IgA nephropathy? That is the question!

Editorial

Gerald B Appel. Clin J Am Soc Nephrol. 2006 May.

. 2006 May;1(3):347-8.

doi: 10.2215/CJN.00330106. Epub 2006 Mar 22.

No abstract available

Comment on

Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group.
Hogg RJ, Lee J, Nardelli N, Julian BA, Cattran D, Waldo B, Wyatt R, Jennette JC, Sibley R, Hyland K, Fitzgibbons L, Hirschman G, Donadio JV Jr, Holub BJ; Southwest Pediatric Nephrology Study Group. Hogg RJ, et al. Clin J Am Soc Nephrol. 2006 May;1(3):467-74. doi: 10.2215/CJN.01020905. Epub 2006 Apr 12. Clin J Am Soc Nephrol. 2006. PMID: 17699247 Clinical Trial.